Company news
INVO Fertility, Inc. news in 2023
INVO Fertility, Inc.'s news releases, calls and decks from 2023, newest first.
NAYA Biosciences Announces Publication of New Data for its CD38-targeted Flex-NK™ Bispecific Antibody in the American Society of Hematology's Blood Journal
December 10, 2023
INVO Bioscience Regains Compliance with Nasdaq Minimum Stockholders' Equity Requirement
November 27, 2023
INVO Reports Record Third Quarter 2023 Financial Results
November 12, 2023
NAYA Biosciences and INVO Bioscience Announce Appointment of Dr. Peter Kash, Ed.D., MBA as Vice Chairman Following Closing of Their Pending Merger
November 9, 2023
INVO Bioscience Announces Commencement of Waiver Solicitation From Holders of the Company's Common Stock Purchase Warrants
November 8, 2023
INVO Bioscience and NAYA Biosciences Announce Definitive Merger Agreement To Establish Expanded Publicly Traded Life Science Company
October 22, 2023
INVO to Participate in the Lytham Partners Fall 2023 Investor Conference
October 10, 2023
INVO bioscience announces adjournment of special meeting of shareholders
September 28, 2023
INVO Reminds Shareholders to Cast Their Vote for Upcoming Special Meeting of Shareholders to be held on Friday, September 29, 2023 at 12: 00 p.m. ET
September 27, 2023
INVO Reports Second Quarter 2023 Financial Results
August 13, 2023
INVO Closes Acquisition of Wisconsin Fertility Institute
August 10, 2023
INVO to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023
August 8, 2023
INVO Bioscience Announces Closing of $4.5 Million Public Offering
August 7, 2023
INVO Bioscience Announces Pricing of $4.5 Million Public Offering
August 3, 2023
INVO Sets Revised Closing Date of Wisconsin Fertility Institute Acquisition and Announces Key Operational Trends to Drive Shareholder Value
August 2, 2023
INVO Announces a 1: 20 Reverse Stock Split Effective Pre-Market Opening on July 28, 2023
July 26, 2023
INVO Receives 510(k) FDA Clearance for Expanded Use of the INVOcell Device
June 26, 2023
INVO Reports First Quarter 2023 Financial Results
May 14, 2023
INVO Bioscience to Report First Quarter 2023 Financial Results on Monday, May 15, 2023
May 7, 2023
INVO Reports Fourth Quarter and Full Year 2022 Financial Results
April 16, 2023
INVO Bioscience to Report Fourth Quarter and Fiscal Year 2022 Financial Results on Monday, April 17, 2023
April 10, 2023
INVO Congratulates Wisconsin Fertility Institute on Being Named One of America's Best Fertility Clinics by Newsweek
April 4, 2023
INVO Provides Preliminary Update on FY2022 Financial Results
March 29, 2023
INVO Bioscience Announces Closing of $3.0 Million Registered Direct Offering
March 26, 2023
INVO Bioscience Announces Pricing of $3.0 Million Registered Direct Offering Priced At-The-Market
March 23, 2023
INVO Signs Binding Agreements to Acquire Wisconsin Fertility Institute
March 19, 2023
INVO Bioscience Enters Distribution Agreement for Taiwan
January 4, 2023
INVO Bioscience Engages Nationally Recognized Physician for New Tampa-based INVO Center
January 2, 2023
Decks in 2023
- INVO Bioscience — Investor Presentation (July 2023)
Investor deck · 26 slides · Jul 24, 2023